RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
定常流型左室補助人工心臓植え込み患者への手術後30日以内のACE阻害薬/ARBの投与(リシノプリル5mgを超える量)は主要な消化管出血及び動静脈奇形関連消化管出血のリスク減少と関連する。 https://t.co/bD3PNrMTYl
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices https://t.co/js2iBpClvo
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @ATRIUMRx: ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduct…
RT @ATRIUMRx: ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduct…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @ATRIUMRx: ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduct…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
RT @JACCJournals: ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction)…
ACE/ARB exposure reduces risk of post-CF-LVAD major GI bleed (57% reduction) and AVM-associated GI bleed (63% reduction) in a dose dependent manner. https://t.co/tPC3r8bz13 #JACC #LVAD @UFHealth https://t.co/2SwKz73tS8
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @ATRIUMRx: ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduct…
RT @ATRIUMRx: ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduct…
ICYMI, recent study demonstrates patients with LVAD who received an ACE inhibitor/ARB within 30 days post-op had a 57% reduction in the risk of major GI bleeding. #cardiotwitter #cardioed
Another reason LVAD patients should remain on RAAS blocking agents (if possible): reduced GI bleeding (observationally) https://t.co/pJmOoeRWq5
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
@petervo88 @EdwardPercy5
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @egarciasayan: The simple intervention of RAAS inhibition with ACEi/ARB reduced GI bleed by 57% after #LVAD implantation. Felt to be rel…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
The simple intervention of RAAS inhibition with ACEi/ARB reduced GI bleed by 57% after #LVAD implantation. Felt to be related to reduction in AVM https://t.co/8EgKLOfkzP @JACCJournals @ACCinTouch #cardiotwitter https://t.co/Au3GIElkxl
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
@KidsHeartDoc @HobbesHuman
RT @JACCJournals: New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https…
New study published in #JACC reports that ACEi/ARBs may help protect against GI and AVM bleeding in #LVAD patients. https://t.co/ewN5Nja3UA https://t.co/XhIAN8f0iA
RT @ralogon: Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices https://t.co…
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices https://t.co/SsBe2pQCcs
RT @accpcardprn: Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD…
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices https://t.co/BiWWQ0HLJt
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Pa... https://t.co/uekqp3J3FD
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices https://t.co/dK2TrDqDhF
RT @accpcardprn: Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD…
【RAS阻害薬でLVAD後の消化管出血減?/ JACC】 LVAD植え込み111例、平均2.1年観察:植え込み後30日以内のRAS-i服用で、消化管大出血の補正後HRは0.43 [95%CI 0.19-0.97]。 https://t.co/7d9MK0IYb2 https://t.co/oOC2NPnaox
RT @accpcardprn: Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD…
RT @accpcardprn: Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD…
RT @accpcardprn: Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD…
Kudos to these pharmacists who identified a potential protective effect of ACEIs on GI bleeding if given early after LVAD implant. https://t.co/7HWPJ2UCIs